PathologybioRxivPreprint
Monoclonal antibody chP3R99 reduces subendothelial retention of atherogenic lipoproteins in Insulin-Resistant rats: Acute treatment versus long-term protection as an idiotypic vaccine for atherosclerosis
Y. Soto, A. Hernandez, R. Sarduy…·S. D. Proctor
This study shows that chP3R99 reduces lipoprotein retention in insulin-resistant rats through acute treatment or long-term vaccination, with no adverse metabolic effects.
DOI 10.1101/2023.08.30.555546